Daniel R Omstead is President of TEKLA LIFE SCIENCES INVESTORS. Currently has a direct ownership of 197,518 shares of HQL, which is worth approximately $2.67 Million. The most recent transaction as insider was on Sep 25, 2023, when has been sold 10,096 shares (Shares of beneficial interest) at a price of $12.39 per share, resulting in proceeds of $125,089. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 198K
0% 3M change
0% 12M change
Total Value Held $2.67 Million

DANIEL R OMSTEAD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2023
BUY
Open market or private purchase
$125,089 $12.39 p/Share
10,096 Added 4.86%
197,518 Shares of beneficial i...
Sep 20 2023
BUY
Open market or private purchase
$152,160 $12.68 p/Share
12,000 Added 6.02%
187,422 Shares of beneficial i...
Aug 11 2021
BUY
Open market or private purchase
$138,497 $21.63 p/Share
6,403 Added 4.19%
146,489 Shares of beneficial i...
Oct 26 2020
BUY
Open market or private purchase
$108,186 $17.52 p/Share
6,175 Added 4.47%
131,835 Shares of beneficial i...
Oct 21 2020
BUY
Open market or private purchase
$105,612 $17.75 p/Share
5,950 Added 4.52%
125,660 Shares of beneficial i...

Also insider at

HQH
TEKLA HEALTHCARE INVESTORS Financial Services
THW
Tekla World Healthcare Fund Financial Services
DRO

Daniel R Omstead

President
Boston, MA

Track Institutional and Insider Activities on HQL

Follow TEKLA LIFE SCIENCES INVESTORS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HQL shares.

Notify only if

Insider Trading

Get notified when an Tekla Life Sciences Investors insider buys or sells HQL shares.

Notify only if

News

Receive news related to TEKLA LIFE SCIENCES INVESTORS

Track Activities on HQL